Literature DB >> 30698682

Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves.

Mathis Gröning1, Naima Borg Tahri2, Lars Søndergaard1, Morten Helvind2, Mads Kristian Ersbøll1, Henrik Ørbæk Andersen2.   

Abstract

OBJECTIVES: The aim was to investigate the incidence of infective endocarditis (IE) in right ventricle-to-pulmonary artery conduits implanted at a Danish tertiary centre.
METHODS: Cases of IE in patients with homografts, Contegra grafts and Melody transcatheter valves were evaluated retrospectively with regard to the likeliness of the diagnosis using the modified Duke criteria and the likeliness of conduit involvement. Incidence rates for IE were calculated 1 and 5 years after valve implantation for all 3 conduits, and separately for Melody subgroups depending on which conduit served as landing zone. Cox regression with time-dependent covariates was used to model the impact of the conduit type on the incidence of IE.
RESULTS: Annualized incidence rates of IE in homografts, Contegra grafts and Melody valves were 0.40% (0.40 cases per 100 patient-years), 0.97% and 6.96% 1 year and 0.27%, 1.12% and 2.89% 5 years after valve implantation. Hazard ratios (HRs) were 3.20 [95% confidence interval (CI) 0.91-11.17, P = 0.069] for Contegra grafts and 11.89 (95% CI 2.91-48.48, P < 0.001) for Melody valves compared to homografts.
CONCLUSIONS: Bovine pulmonary conduits were more prone to endocarditis, with Melody valves being the most frequently infected. HRs for the risk of suffering from endocarditis were substantially higher for Melody valves and Contegra grafts compared to homografts, although this finding was only statistically significant for Melody valves and not for Contegra grafts.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Contegra; Homograft; Infective endocarditis; Melody; Transcatheter pulmonary valve replacement

Mesh:

Year:  2019        PMID: 30698682     DOI: 10.1093/ejcts/ezy478

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

Review 1.  Infective endocarditis in paediatric population.

Authors:  Loay Eleyan; Ameer Ahmed Khan; Gledisa Musollari; Ashwini Suresh Chandiramani; Simran Shaikh; Ahmad Salha; Abdulla Tarmahomed; Amer Harky
Journal:  Eur J Pediatr       Date:  2021-04-14       Impact factor: 3.183

2.  Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Authors:  Takaya Hoashi; Hajime Ichikawa; Keiichi Hirose; Naohiro Horio; Takahisa Sakurai; Hironori Matsuhisa; Yoshihiro Ohsima; Hajime Sakurai; Shingo Kasahara; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

3.  Nationwide Registry-Based Analysis of Infective Endocarditis Risk After Pulmonary Valve Replacement.

Authors:  Clara Stammnitz; Dörte Huscher; Ulrike M M Bauer; Aleksandra Urban; Johannes Nordmeyer; Stephan Schubert; Joachim Photiadis; Felix Berger; Sabine Klaassen
Journal:  J Am Heart Assoc       Date:  2022-02-18       Impact factor: 5.501

4.  Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot.

Authors:  Eva Havers-Borgersen; Jawad H Butt; Morten Smerup; Gunnar H Gislason; Christian Torp-Pedersen; Mathis Gröning; Michael Rahbek Schmidt; Lars Søndergaard; Lars Køber; Emil L Fosbøl
Journal:  J Am Heart Assoc       Date:  2021-11-03       Impact factor: 5.501

5.  Risk factors for early adverse outcomes after bovine jugular vein conduit implantation: influence of oversized conduit on the outcomes.

Authors:  Dong-Hee Kim; Young Kern Kwon; Eun Seok Choi; Bo Sang Kwon; Chun Soo Park; Tae-Jin Yun
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-09-09

6.  Impact of valve fenestrations and structural changes in homografts on the long-term outcome in the recipient.

Authors:  Ida Axelsson; Torsten Malm; Johan Nilsson
Journal:  Cell Tissue Bank       Date:  2021-02-12       Impact factor: 1.522

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.